Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 8950976)

1.

Stra6, a retinoic acid-responsive gene, participates in p53-induced apoptosis after DNA damage.

Carrera S, Cuadrado-Castano S, Samuel J, Jones GD, Villar E, Lee SW, Macip S.

Cell Death Differ. 2013 Jul;20(7):910-9. doi: 10.1038/cdd.2013.14. Epub 2013 Mar 1.

2.

Regulation of senescence in cancer and aging.

Kong Y, Cui H, Ramkumar C, Zhang H.

J Aging Res. 2011 Mar 8;2011:963172. doi: 10.4061/2011/963172.

3.

Cellular senescence as a target in cancer control.

Vergel M, Marin JJ, Estevez P, Carnero A.

J Aging Res. 2010 Dec 30;2011:725365. doi: 10.4061/2011/725365.

4.

p63 regulates proliferation and differentiation of developmentally mature keratinocytes.

Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA.

Genes Dev. 2006 Nov 15;20(22):3185-97.

5.

ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H, Kumamoto K, Wincovitch S, Garfield SH, McMenamin M, Nagashima M, Grossman SR, Appella E, Harris CC.

Mol Cell Biol. 2005 Aug;25(15):6639-48.

6.
8.

Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.

Satyanarayana A, Wiemann SU, Buer J, Lauber J, Dittmar KE, W├╝stefeld T, Blasco MA, Manns MP, Rudolph KL.

EMBO J. 2003 Aug 1;22(15):4003-13.

9.

Tracking the cell cycle origins for escape from topotecan action by breast cancer cells.

Feeney GP, Errington RJ, Wiltshire M, Marquez N, Chappell SC, Smith PJ.

Br J Cancer. 2003 Apr 22;88(8):1310-7.

10.

Cellular Senescence: Ex Vivo p53-Dependent Asymmetric Cell Kinetics.

Rambhatla L, Bohn SA, Stadler PB, Boyd JT, Coss RA, Sherley JL.

J Biomed Biotechnol. 2001;1(1):28-37.

11.
12.

Activation of p53 protein by telomeric (TTAGGG)n repeats.

Milyavsky M, Mimran A, Senderovich S, Zurer I, Erez N, Shats I, Goldfinger N, Cohen I, Rotter V.

Nucleic Acids Res. 2001 Dec 15;29(24):5207-15.

13.

Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.

Carnero A, Hudson JD, Hannon GJ, Beach DH.

Nucleic Acids Res. 2000 Jun 1;28(11):2234-41.

14.

Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage.

Webley K, Bond JA, Jones CJ, Blaydes JP, Craig A, Hupp T, Wynford-Thomas D.

Mol Cell Biol. 2000 Apr;20(8):2803-8.

15.

Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis.

Bond JA, Haughton MF, Rowson JM, Smith PJ, Gire V, Wynford-Thomas D, Wyllie FS.

Mol Cell Biol. 1999 Apr;19(4):3103-14.

17.

Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas.

Fazeli A, Steen RG, Dickinson SL, Bautista D, Dietrich WF, Bronson RT, Bresalier RS, Lander ES, Costa J, Weinberg RA.

Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10199-204.

18.

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

Sugrue MM, Shin DY, Lee SW, Aaronson SA.

Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9648-53.

19.

Adenovirus type 12 early region 1B 54K protein significantly extends the life span of normal mammalian cells in culture.

Gallimore PH, Lecane PS, Roberts S, Rookes SM, Grand RJ, Parkhill J.

J Virol. 1997 Sep;71(9):6629-40.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk